Please assess the completion status of the following clinical trial:

Trial Title: Topical Multiple Ascending Dose Study for PF-06423264

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: None
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1
- Number of Arms: 18.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy males and female of non-childbearing potential;~* Body Mass Index 17.5-35.5 kg/m2;~* Body weight \>50 kg;~Exclusion Criteria:~* Evidence of history of clinically significant hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic, or allergic disease (including drug allergises, but excluding untreated, asymptomatic, seasonal allergies at time of dosing)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: t

Study Arms:
- Part A_Cohort 1_Active (Type: EXPERIMENTAL): Multiple ascending dose of PF-06423264
- Part A_Cohort 1_Placebo (Type: PLACEBO_COMPARATOR): Multiple dose of placebo
- Part A_Cohort 2_Active (Type: EXPERIMENTAL): Multiple ascending dose of PF-06423264
- Part A_Cohort 2_Placebo (Type: PLACEBO_COMPARATOR): Multiple dose of placebo
- Part A_Cohort 3_Active (Type: EXPERIMENTAL): Multiple ascending dose of PF-06423264
- Part A_Cohort 3_Placebo (Type: PLACEBO_COMPARATOR): Multiple dose of placebo
- Part A_Cohort 4_Active (Type: EXPERIMENTAL): Multiple ascending dose of PF-06423264
- Part A_Cohort 4_Placebo (Type: PLACEBO_COMPARATOR): Multiple dose of placebo
- Part A_Cohort 5_Active (Type: EXPERIMENTAL): Multiple ascending dose of PF-06423264
- Part A_Cohort 5_Placebo (Type: PLACEBO_COMPARATOR): Multiple dose of placebo
- Part A_Cohort 6_Active (Type: EXPERIMENTAL): Multiple ascending dose of PF-06423264
- Part A_Cohort 6_Placebo (Type: PLACEBO_COMPARATOR): Multiple dose of placebo
- Part A_Cohort 7_Active (Type: EXPERIMENTAL): Multiple ascending dose of PF-06423264
- Part A_Cohort 7_Placebo (Type: PLACEBO_COMPARATOR): Multiple ascending dose of placebo
- Part B_Cohort 1_Active (Type: EXPERIMENTAL): Multiple doses of PF-06423264
- Part B_Cohort 1_Placebo (Type: PLACEBO_COMPARATOR): Multiple doses of placebo
- Part B_Cohort 2_Active (Type: EXPERIMENTAL): Multiple doses of PF-06423264
- Part B_Cohort 2_Placebo (Type: PLACEBO_COMPARATOR): Multiple doses of placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).